Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2010, Article ID 747852, 7 pages
http://dx.doi.org/10.4061/2010/747852
Research Article

Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic

1Laboratoire CSPBAT, C2B, FRE 3043 CNRS, Université Paris 13, 93017 Bobigny Cedex, France
2Service de Médecine Nucléaire, Hôpital Avicenne, APHP, 93009 Bobigny Cedex, France
3Service de Radiologie, Hôpital Bichat, APHP, U 698 ISERM, Université Paris 7, 75877 Paris Cedex 18, France
4UPRES 3410 Biothérapies Bénéfices et Risques, Université Paris 13, 93017 Bobigny Cedex, France
5Plateforme d'IRM du Petit Animal, U 970 INSERM, Université Paris 5, 75908 Paris Cedex 10, France

Received 14 January 2010; Revised 3 March 2010; Accepted 19 April 2010

Academic Editor: Annie Kung

Copyright © 2010 Y. Lalatonne et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Martin and V. Grill, “Bisphosphonates—mechanisms of action,” Australian Prescriber, vol. 23, no. 6, pp. 130–132, 2000. View at Google Scholar · View at Scopus
  2. J. Soltau and J. Drevs, “The role of bisphosphonates in oncology,” Drugs of the Future, vol. 29, no. 9, pp. 911–921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Fisher, M. J. Rogers, J. M. Halasy et al., “Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 1, pp. 133–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Bauer and T. M. Link, “Advances in osteoporosis imaging,” European Journal of Radiology, vol. 71, no. 3, pp. 440–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Lawaczeck, M. Menzel, and H. Pietsch, “Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging,” Applied Organometallic Chemistry, vol. 18, no. 10, pp. 506–513, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. C. Berry, “Progress in functionalization of magnetic nanoparticles for applications in biomedicine,” Journal of Physics D, vol. 42, no. 22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. K. Jain, M. K. Reddy, M. A. Morales, D. L. Leslie-Pelecky, and V. Labhasetwar, “Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats,” Molecular Pharmaceutics, vol. 5, no. 2, pp. 316–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Lalatonne, C. Paris, J. M. Serfaty, P. Weinmann, M. Lecouvey, and L. Motte, “Bis-phosphonates-ultra small superparamagnetic iron oxide nanoparticles: a platform towards diagnosis and therapy,” Chemical Communications, no. 22, pp. 2553–2555, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Benyettou, Y. Lalatonne, O. Sainte-Catherine, M. Monteil, and L. Motte, “Superparamagnetic nanovector with anti-cancer properties: γFe2O3@Zoledronate,” International Journal of Pharmaceutics, vol. 379, no. 2, pp. 324–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Portet, B. Denizot, E. Rump, F. Hindre, J.-J. Le Jeune, and P. Jallet, “Comparative biodistribution of thin-coated iron oxide nanoparticles TCION: effect of different bisphosphonate coatings,” Drug Development Research, vol. 54, no. 4, pp. 173–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Fishbein, I. S. Alferiev, O. Nyanguile et al., “Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 1, pp. 159–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Lecouvey, I. Mallard, T. Bailly, R. Burgada, and Y. Leroux, “A mild and efficient one-pot synthesis of 1-hydroxymethylene-1,1-bisphosphonic acids. Preparation of new tripod ligands,” Tetrahedron Letters, vol. 42, no. 48, pp. 8475–8478, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. P. I. Nikitin and P. M. Vetoshko, Patent of Russian Federation RU 2166751, 2000, EP 1262766 publication, 2002.
  14. L. Lenglet, “Multiparametric magnetic immunoassays utilizing non-linear signatures of magnetic labels,” Journal of Magnetism and Magnetic Materials, vol. 321, no. 10, pp. 1639–1643, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Errassifi, A. Barroug, S. Sarda, C. Rey, A. Lebugle, and A. Legrouri, “Etude de l'interaction du risedronate avec un phosphate de calcium analogue au minéral osseux,” in Proceedings of the 2nd International Conference on the Valorization of Phosphates and Phosphorous Compounds, vol. 4, pp. 293–300, 2006.
  16. Y. Lalatonne, L. Motte, V. Russier, A. T. Ngo, P. Bonville, and M. P. Pileni, “Mesoscopic structures of nanocrystals: collective magnetic properties due to the alignment of nanocrystals,” Journal of Physical Chemistry B, vol. 108, no. 6, pp. 1848–1854, 2004. View at Google Scholar · View at Scopus
  17. R. D. Peacock, “The intensities of lantahnide f-f transitions,” Structure and Bonding, vol. 22, pp. 83–122, 1975. View at Google Scholar
  18. E. Podstawka, R. Borszowska, M. Grabowska, M. Drąg, P. Kafarski, and L. M. Proniewicz, “Investigation of molecular structures and adsorption mechanisms of phosphonodipeptides by surface-enhanced Raman, Raman, and infrared spectroscopies,” Surface Science, vol. 599, no. 1–3, pp. 207–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. K. V. P. M. Shafi, A. Ulman, X. Yan et al., “Sonochemical synthesis of functionalized amorphous iron oxide nanoparticles,” Langmuir, vol. 17, no. 16, pp. 5093–5097, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Gao, L. Dickinson, C. Grozinger, F. G. Morin, and L. Reven, “Self-assembled monolayers of alkylphosphonic acids on metal oxides,” Langmuir, vol. 12, no. 26, pp. 6429–6435, 1996. View at Google Scholar · View at Scopus
  21. Y. Lalatonne, F. Benyettou, D. Bonnin et al., “Characterization of magnetic labels for bioassays,” Journal of Magnetism and Magnetic Materials, vol. 321, no. 10, pp. 1653–1657, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. G. H. Nancollas, R. Tang, R. J. Phipps et al., “Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite,” Bone, vol. 38, no. 5, pp. 617–627, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. C. D'Andrea and A. Y. Fadeev, “Covalent surface modification of calcium hydroxyapatite using n-alkyl- and n-fluoroalkylphosphonic acids,” Langmuir, vol. 19, no. 19, pp. 7904–7910, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. L. C. Hofbauer, F. Gori, B. L. Riggs et al., “Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis,” Endocrinology, vol. 140, no. 10, pp. 4382–4389, 1999. View at Google Scholar · View at Scopus